Oman vs South-East Asia (WHO region): Pneumococcal conjugate second or third-dose vaccines (PCVc)

Oman
99.0%
in 2025
South-East Asia (WHO region)
92.0%
in 2025
Oman rank
1st
South-East Asia (WHO region) rank
1st

Pneumococcal conjugate second or third-dose vaccines (PCVc) over time

  • Oman
  • South-East Asia (WHO region)
020406080100200820162025

How they compare

Oman currently reports 99.0% against 92.0% in South-East Asia (WHO region), a difference of 7.0%.

That makes Oman's figure about 1.1 times South-East Asia (WHO region)'s.

The two have swapped places 1 time across 18 shared years of data; in 2008 it was South-East Asia (WHO region) ahead.

Oman ranks 1st and South-East Asia (WHO region) ranks 1st of 194 countries.

Oman has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Oman South-East Asia (WHO region) Difference Ahead
2000s 48.0% 0.0% 48.0% Oman
2010s 98.8% 7.8% 91.0% Oman
2020s 98.7% 66.0% 32.7% Oman

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Oman or South-East Asia (WHO region)?
Oman, at 99.0% against 92.0% in South-East Asia (WHO region) as of 2025.
What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Oman and South-East Asia (WHO region)?
7.0%, with Oman ahead.
How many years of comparable data are there for Oman and South-East Asia (WHO region)?
18 years are reported by both, from 2008 to 2025.
How do Oman and South-East Asia (WHO region) rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
Oman ranks 1st and South-East Asia (WHO region) ranks 1st of 194 countries.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Oman vs South-East Asia (WHO region): Pneumococcal conjugate second or third-dose vaccines (PCVc). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 05 September 2026, from https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/oman/south-east-asia-who-region/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/oman/south-east-asia-who-region/">Oman vs South-East Asia (WHO region): Pneumococcal conjugate second or third-dose vaccines (PCVc)</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
207 places, 3,723 data points, 2008–2025
Last refreshed